Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
Identifieur interne : 003F61 ( PubMed/Checkpoint ); précédent : 003F60; suivant : 003F62Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
Auteurs : T R Burkot [Vanuatu] ; G. Taleo ; V. Toeaso ; K. IchimoriSource :
- Annals of tropical medicine and parasitology [ 0003-4983 ] ; 2002.
Descripteurs français
- KwdFr :
- Albendazole (usage thérapeutique), Animaux, Chlorure de sodium (usage thérapeutique), Culicidae (parasitologie), Diéthylcarbamazine (usage thérapeutique), Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (transmission), Filariose lymphatique (épidémiologie), Humains, Iles du Pacifique (épidémiologie), Lutte contre les moustiques (), Maladies endémiques (), Vecteurs de maladie.
- MESH :
- parasitologie : Culicidae.
- usage thérapeutique : Albendazole, Chlorure de sodium, Diéthylcarbamazine, Filaricides, Filariose lymphatique.
- épidémiologie : Filariose lymphatique, Iles du Pacifique.
- Animaux, Filariose lymphatique, Humains, Lutte contre les moustiques, Maladies endémiques, Vecteurs de maladie.
English descriptors
- KwdEn :
- Albendazole (therapeutic use), Animals, Culicidae (parasitology), Diethylcarbamazine (therapeutic use), Disease Vectors, Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Elephantiasis, Filarial (transmission), Endemic Diseases (prevention & control), Filaricides (therapeutic use), Humans, Mosquito Control (methods), Pacific Islands (epidemiology), Sodium Chloride (therapeutic use).
- MESH :
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides, Sodium Chloride.
- geographic , epidemiology : Pacific Islands.
- epidemiology : Elephantiasis, Filarial.
- methods : Mosquito Control.
- parasitology : Culicidae.
- prevention & control : Elephantiasis, Filarial, Endemic Diseases.
- transmission : Elephantiasis, Filarial.
- Animals, Disease Vectors, Humans.
Abstract
The Pacific Programme for the Elimination of Lymphatic Filariasis (PacELF) - the first regional campaign to attempt to eliminate filariasis as a public-health problem - is using five, annual, mass drug administrations (MDA) of diethylcarbamazine (DEC) plus albendazole to stop transmission. In 2001, nine countries and territories covered by the programme had begun annual MDA campaigns, with population treatment coverages ranging from 52% to 95%. By the end of 2002, it is anticipated that 11 countries/territories will have begun such MDA campaigns. Even with high MDA coverage, the efficiency of Aedes polynesiensis as a vector of Wuchereria bancrofti may limit the effectiveness of the elimination campaigns in some countries. In areas of limited MDA coverage, additional strategies, such as vector control (as a adjunct to the MDA), or alternative approaches, such as the use of DEC-fortified salt, may be necessary to stop transmission.
DOI: 10.1179/000349802125002419
PubMed: 12625919
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:12625919Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.</title>
<author><name sortKey="Burkot, T R" sort="Burkot, T R" uniqKey="Burkot T" first="T R" last="Burkot">T R Burkot</name>
<affiliation wicri:level="1"><nlm:affiliation>Pacific Regional Vector Borne Diseases Project, Port Vila, Vanuatu. trburkot@aol.com</nlm:affiliation>
<country xml:lang="fr">Vanuatu</country>
<wicri:regionArea>Pacific Regional Vector Borne Diseases Project, Port Vila</wicri:regionArea>
<wicri:noRegion>Port Vila</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Taleo, G" sort="Taleo, G" uniqKey="Taleo G" first="G" last="Taleo">G. Taleo</name>
</author>
<author><name sortKey="Toeaso, V" sort="Toeaso, V" uniqKey="Toeaso V" first="V" last="Toeaso">V. Toeaso</name>
</author>
<author><name sortKey="Ichimori, K" sort="Ichimori, K" uniqKey="Ichimori K" first="K" last="Ichimori">K. Ichimori</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12625919</idno>
<idno type="pmid">12625919</idno>
<idno type="doi">10.1179/000349802125002419</idno>
<idno type="wicri:Area/PubMed/Corpus">004340</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004340</idno>
<idno type="wicri:Area/PubMed/Curation">004340</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004340</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004340</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004340</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.</title>
<author><name sortKey="Burkot, T R" sort="Burkot, T R" uniqKey="Burkot T" first="T R" last="Burkot">T R Burkot</name>
<affiliation wicri:level="1"><nlm:affiliation>Pacific Regional Vector Borne Diseases Project, Port Vila, Vanuatu. trburkot@aol.com</nlm:affiliation>
<country xml:lang="fr">Vanuatu</country>
<wicri:regionArea>Pacific Regional Vector Borne Diseases Project, Port Vila</wicri:regionArea>
<wicri:noRegion>Port Vila</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Taleo, G" sort="Taleo, G" uniqKey="Taleo G" first="G" last="Taleo">G. Taleo</name>
</author>
<author><name sortKey="Toeaso, V" sort="Toeaso, V" uniqKey="Toeaso V" first="V" last="Toeaso">V. Toeaso</name>
</author>
<author><name sortKey="Ichimori, K" sort="Ichimori, K" uniqKey="Ichimori K" first="K" last="Ichimori">K. Ichimori</name>
</author>
</analytic>
<series><title level="j">Annals of tropical medicine and parasitology</title>
<idno type="ISSN">0003-4983</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (therapeutic use)</term>
<term>Animals</term>
<term>Culicidae (parasitology)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Disease Vectors</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Elephantiasis, Filarial (transmission)</term>
<term>Endemic Diseases (prevention & control)</term>
<term>Filaricides (therapeutic use)</term>
<term>Humans</term>
<term>Mosquito Control (methods)</term>
<term>Pacific Islands (epidemiology)</term>
<term>Sodium Chloride (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (usage thérapeutique)</term>
<term>Animaux</term>
<term>Chlorure de sodium (usage thérapeutique)</term>
<term>Culicidae (parasitologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (transmission)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Iles du Pacifique (épidémiologie)</term>
<term>Lutte contre les moustiques ()</term>
<term>Maladies endémiques ()</term>
<term>Vecteurs de maladie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
<term>Sodium Chloride</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Pacific Islands</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mosquito Control</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Culicidae</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Culicidae</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Endemic Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Chlorure de sodium</term>
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Iles du Pacifique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Vectors</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Lutte contre les moustiques</term>
<term>Maladies endémiques</term>
<term>Vecteurs de maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Pacific Programme for the Elimination of Lymphatic Filariasis (PacELF) - the first regional campaign to attempt to eliminate filariasis as a public-health problem - is using five, annual, mass drug administrations (MDA) of diethylcarbamazine (DEC) plus albendazole to stop transmission. In 2001, nine countries and territories covered by the programme had begun annual MDA campaigns, with population treatment coverages ranging from 52% to 95%. By the end of 2002, it is anticipated that 11 countries/territories will have begun such MDA campaigns. Even with high MDA coverage, the efficiency of Aedes polynesiensis as a vector of Wuchereria bancrofti may limit the effectiveness of the elimination campaigns in some countries. In areas of limited MDA coverage, additional strategies, such as vector control (as a adjunct to the MDA), or alternative approaches, such as the use of DEC-fortified salt, may be necessary to stop transmission.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12625919</PMID>
<DateCreated><Year>2003</Year>
<Month>03</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2003</Year>
<Month>04</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4983</ISSN>
<JournalIssue CitedMedium="Print"><Volume>96 Suppl 2</Volume>
<PubDate><Year>2002</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Annals of tropical medicine and parasitology</Title>
<ISOAbbreviation>Ann Trop Med Parasitol</ISOAbbreviation>
</Journal>
<ArticleTitle>Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.</ArticleTitle>
<Pagination><MedlinePgn>S61-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The Pacific Programme for the Elimination of Lymphatic Filariasis (PacELF) - the first regional campaign to attempt to eliminate filariasis as a public-health problem - is using five, annual, mass drug administrations (MDA) of diethylcarbamazine (DEC) plus albendazole to stop transmission. In 2001, nine countries and territories covered by the programme had begun annual MDA campaigns, with population treatment coverages ranging from 52% to 95%. By the end of 2002, it is anticipated that 11 countries/territories will have begun such MDA campaigns. Even with high MDA coverage, the efficiency of Aedes polynesiensis as a vector of Wuchereria bancrofti may limit the effectiveness of the elimination campaigns in some countries. In areas of limited MDA coverage, additional strategies, such as vector control (as a adjunct to the MDA), or alternative approaches, such as the use of DEC-fortified salt, may be necessary to stop transmission.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burkot</LastName>
<ForeName>T R</ForeName>
<Initials>TR</Initials>
<AffiliationInfo><Affiliation>Pacific Regional Vector Borne Diseases Project, Port Vila, Vanuatu. trburkot@aol.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Taleo</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Toeaso</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ichimori</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Trop Med Parasitol</MedlineTA>
<NlmUniqueID>2985178R</NlmUniqueID>
<ISSNLinking>0003-4983</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>451W47IQ8X</RegistryNumber>
<NameOfSubstance UI="D012965">Sodium Chloride</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F4216019LN</RegistryNumber>
<NameOfSubstance UI="D015766">Albendazole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009033" MajorTopicYN="N">Culicidae</DescriptorName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004199" MajorTopicYN="N">Disease Vectors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009032" MajorTopicYN="N">Mosquito Control</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010139" MajorTopicYN="N" Type="Geographic">Pacific Islands</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012965" MajorTopicYN="N">Sodium Chloride</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2003</Year>
<Month>4</Month>
<Day>4</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2003</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12625919</ArticleId>
<ArticleId IdType="doi">10.1179/000349802125002419</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Vanuatu</li>
</country>
</list>
<tree><noCountry><name sortKey="Ichimori, K" sort="Ichimori, K" uniqKey="Ichimori K" first="K" last="Ichimori">K. Ichimori</name>
<name sortKey="Taleo, G" sort="Taleo, G" uniqKey="Taleo G" first="G" last="Taleo">G. Taleo</name>
<name sortKey="Toeaso, V" sort="Toeaso, V" uniqKey="Toeaso V" first="V" last="Toeaso">V. Toeaso</name>
</noCountry>
<country name="Vanuatu"><noRegion><name sortKey="Burkot, T R" sort="Burkot, T R" uniqKey="Burkot T" first="T R" last="Burkot">T R Burkot</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F61 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003F61 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:12625919 |texte= Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:12625919" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |